Back

Ketone bodies independently of metabolic pathway attenuate cardiac hypertrophy through β-hydroxybutyrylation

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Cardiac hypertrophy and pressure overload Cardiac Hypertrophy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jiayi Du

West China Hospital, Sichuan University, Chengdu (China)

6 More presentations in this session

Presentation thumbnail
Endothelial redox signalling safeguards metabolic and transcriptional integrity and blocks middle-age cardiac hypertrophy
Ms M. Drekolia (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Sestrin2 protects against pressure overload–induced pathological cardiac hypertrophy via ULK1
Mr T. Liu (CN)
Abstract Slides
Presentation thumbnail
The Role of Neuropeptide Y in Human Cardiac Hypertrophy after Myocardial Infarction
Miss L. Ganzer (GB)
Abstract Slides
Presentation thumbnail
A porcine model of pressure overload–induced cardiac hypertrophy via catheter-based aortic stent implantation for aav-mediated gene therapy studies
Ms M. Corsten (Munich, DE)
Presentation thumbnail
Empagliflozin promotes reverse remodeling via cardiometabolic reprogramming in established pressure-overload left ventricular hypertrophy
Doctor M. Ernst (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Cardiac hypertrophy and pressure overload

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Myocardial ketone body oxidation underlies the salutary effects of SGLT2 inhibitor treatment in heart failure
21 May 2023
thumbnail
Congress Presentation
Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity
27 August 2021
thumbnail
Congress Presentation
The role of acetyltransferase PCAF in cardiac remodeling
21 May 2023
thumbnail
Congress Presentation
Epitranscriptomics and nonconventional cardioprotective interventions
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources